These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20415546)

  • 1. Pharmacogenomics--10 years of progress: a cardiovascular perspective.
    Winkelmann BR; Herrington D
    Pharmacogenomics; 2010 May; 11(5):613-6. PubMed ID: 20415546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ask the experts: pharmacogenomics and genome-wide association studies.
    Hakonarson H
    Pharmacogenomics; 2013 Mar; 14(4):365-8. PubMed ID: 23438883
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interview: a discussion on genome-wide associations in pharmacogenomics.
    Motsinger-Reif A
    Pharmacogenomics; 2013 Mar; 14(4):361-3. PubMed ID: 23438882
    [No Abstract]   [Full Text] [Related]  

  • 6. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Nebert DW; Zhang G; Vesell ES
    Drug Metab Rev; 2008; 40(2):187-224. PubMed ID: 18464043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and pharmacoepigenomics in pediatric medicine.
    Shastry BS
    Methods Mol Biol; 2014; 1175():671-85. PubMed ID: 25150880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern-recognition techniques with haplotype analysis in pharmacogenomics.
    Lin E; Hwang Y; Liang KH; Chen EY
    Pharmacogenomics; 2007 Jan; 8(1):75-83. PubMed ID: 17187511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to personalized medicine for asthma: where are we?
    Weiss ST
    J Allergy Clin Immunol; 2012 Feb; 129(2):327-34. PubMed ID: 22284929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics.
    Stephens JC
    Mol Diagn; 1999 Dec; 4(4):309-17. PubMed ID: 10671641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?
    Vizirianakis IS
    Pharmacogenomics; 2005 Oct; 6(7):701-11. PubMed ID: 16207147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNPs and haplotypes: genetic markers for disease and drug response (review).
    Shastry BS
    Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compilation of a comprehensive gene panel for systematic assessment of genes that govern an individual's drug responses.
    Feng J; Sun J; Wang MZ; Zhang Z; Kim ST; Zhu Y; Sun J; Xu J
    Pharmacogenomics; 2010 Oct; 11(10):1403-25. PubMed ID: 21047203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine - the promised land: are we there yet?
    Li C
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.